1Lewis R, Bennett CJ, Borkon WD, et al. Patient and partner satisfaction with Viagra ( sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire [J]. Urology, 2001,57 (5) : 9602965.
2Carson CC, Burnett AL, Levine LA, et al. The efficacy of sildenafil citrate (Viagra) in clinical populations: an update[J]. Urology, 2002, 60 (2 Supp 1 2) : 12227.
3De Berardis G, FranciosiM, Belfiglio M, et al. Erectile dysfunction and quality of life in type 2 diabetic patients: a serious p roblem too often overlooked [J]. Diabetes Care, 2002, 25 : 2842291.
4Padma2Nathan H, Hellstrom WJ, Kaiser FE, et al. Treatment of men with erectile dysfunction with transurethral alp rostadil. Medicated Urethral System for Erection (MUSE) Study Group[J]. New Engl J Med, 1997, 336 : 127.
5Goldstein I, Lue TF, Padma2Nathan H, et al.Oral sildenafil in the treatment of erectile dysfunction [J].New Engl J Med, 1998, 338: 13972 -1404.
2Jackson G, Gillies H, Osterloh I. Past, present, and future: a 7-year update of Viagra ( sildenafil citrate) [ J ]. int J Clin Pract,2005, 59(6) :680-691.
3Boolell M, GepiAttee S, Gin-gell JC, et al. Sildenafil, a novel effective oral therapy for male erectile dysfunction[ J]. Br J Urol,1996, 78(2) :257-261.
4Sadovsky R, Miller T, Moskowitz M, et al. Three year update of sildenafil citrate (Viagra) efficacy and safety [ J]. int J Clin Pract, 2001, 55(2) :115-128.
5Campbell HE. Clinical monograph for drug formulary review: erectile dysfunction agents [ J ]. J Manag Care Phann, 2005, 11(2) :151-171.
6Boshier A, Wilton LV, Shakir SA, et al. Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999[J]. BJU Int, 2004, 93(6) :796-801.
7DeBusk RF, Pepine CJ, Glasser DB, et al. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease[ J]. Am J Cardiol, 2004, 93 (2) : 147-153.
8Katz SD, Parker JD, Glasser DB, et al. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure[J]. Am J Cardiol, 2005, 95( 1 ) :36-42.
9Hutter AM Jr. Role of the cardiologist : clinical aspects of managing erectile dysfunction [ J]. Clin Cardiol, 2004, 27 (4 Suppl1 ) :13-17.
10Jackson G, Benjamin N, Jackson N, et al. Effects of sildenafil citrate on human homod~namics [ J]. Am J Cardiol, 1999, 83(5A) : 13C-20C.
7Sablotzki A, Hent schel T, Hofmann S ,et al. Inhaled aerosolized iloprost in t he evaluation of heart t ransplant candidates -experiences with 45 cases. J Clin Anesth,2006,18 : 1082113.
8Peter N K. Simvastatin t reatment of pulmonary hypertension: an observational case serieS. Chest, 2005,127 : 1446 - 1452.
9Ishikura K, Yamada N, ItO M, et al. Beneficial acute effect s of Rho2kinase inhibitor in patient s wit h pulmonary arterial hy2pertension. Circ J, 2006., 70 : 1742178.
10Stenmark KR, McMurt ry IF. Vascular remodeling versus vasoconst fiction in chronic hypoxic pulmonary hypertension: Atime for reappraisal. Cir Res, 2005, 97:95298.
